Table 4. Correlation between VCTE fibrosis stage and biopsy fibrosis stage.

Patient group	Sample size	Fibrosis stages	Kendall’s tau
All patients	97	All stages	0.426 (p<0.001)
		Stage 0–1 vs. 2–4	0.32 (p=0.002)
		Stage 0–3 vs. 4	0.408 (p<0.001)
NAFLD only	41	All stages	0.38 (p=0.004)
		Stage 0–1 vs. 2–4	0.309 (p=0.053)
		Stage 0–3 vs. 4	0.382 (p=0.017)
Non-NAFLD only	56	All stages	0.461 (p<0.001)
		Stage 0–1 vs. 2–4	0.31 (p=0.022)
		Stage 0–3 vs. 4	0.442 (p=0.001)

NAFLD, nonalcoholic fatty liver disease; VCTE, vibration-controlled transient elastography.